Evidence map›Paper›PMID 2501443›Full record

ArticleThe Journal of experimental medicine1989

Functional immunoglobulin light chain genes are replaced by ongoing rearrangements of germline V kappa genes to downstream J kappa segment in a murine B cell line.

S Levy, M J Campbell, R Levy

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Receptor selection in B and T lymphocytes.Annual review of immunology · 2000
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S LevyDepartment of Medicine, Stanford University School of Medicine, California 94305.
M J Campbell
R Levy

Funding

TRIGGERING CELL DEATH IN B CELL LYMPHOMAP01CA034233 · NCI · STANFORD UNIVERSITY · PI FELSHER, DEAN W · 1985 to 2010
$19.5M
ANTIIDIOTYPE THERAPY OF HUMAN B CELL MALIGNANCYR37CA033399 · NCI · STANFORD UNIVERSITY · PI LEVY, RONALD · 1988 to 2007
$4.5M
HUMAN ANTITUMOR THERAPY WITH MONOCLONAL ANTIBODIESR01CA033399 · NCI · STANFORD UNIVERSITY · PI LEVY, RONALD · 1985 to 1998
–
NCI NIH HHS CA-33399NCI NIH HHS CA-34233NIAID NIH HHS AI-07290
6 · The paper itself

Abstract

A murine B cell lymphoma (38C13) was subjected to immunoselection with mAbs directed against the idiotypic determinants of its cell surface Ig. Variants emerged with altered Ig receptors containing identical heavy chains but different light chains. The functional light chain genes in these variants were composed of V kappa segments drawn from the V kappa Ox-1 family, which had replaced the V kappa gene expressed by the parental tumor by rearranging to downstream J kappa segments. Rearrangement at the kappa locus continued to occur spontaneously, giving rise to secondary and tertiary variants at a rate of 1.9 x 10(-4) per cell per generation. Variants were isolated that had ceased production of surface Ig but went on to rearrange again and to become surface Ig+. The Ig- state may be an intermediate step providing a stimulus for continued rearrangement. This process provides an additional mechanism for generating diversity within B cell clones and expands the use of the available repertoire of Ig genes.

Indexed as

Gene Rearrangement, B-Lymphocyte, Light ChainGenes, ImmunoglobulinAnimalsBase SequenceB-LymphocytesCell LineImmunoglobulin IdiotypesImmunoglobulin Joining RegionImmunoglobulin Light ChainsImmunoglobulin Variable RegionMiceMolecular Sequence DataTranscription, GeneticImmunoglobulin IdiotypesImmunoglobulin Joining RegionImmunoglobulin Light ChainsImmunoglobulin Variable Region

Identifiers

PMID2501443
PMCPMC2189373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.